Quarterly report pursuant to Section 13 or 15(d)

Fair Value Measurements and Hierarchy - Carrying Value of Financial Instruments (Details)

v3.22.2.2
Fair Value Measurements and Hierarchy - Carrying Value of Financial Instruments (Details) - USD ($)
3 Months Ended
Dec. 31, 2021
Mar. 31, 2022
Mar. 31, 2021
Fair Value Measurements and Hierarchy      
Financial Designation, Predecessor and Successor [Fixed List] Successor Successor Predecessor
Cash $ 140,477,586 $ 110,345,801 $ 22,341,413
Restricted Cash 356,286 356,242 $ 3,687,918
Clinic Fees and Insurance Receivables, Net 1,090,104 767,396  
Other Receivables 726,903 587,833  
Accounts Payable and Accrued Expenses 17,730,683 21,726,910  
Warrant liabilities $ 11,382,826 $ 17,244,101